Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) EBIT Margin (2009 - 2026)

Updated

Immucell's EBIT Margin was 11.91% in Q3 2026, up 11.55 percentage points from 0.36% a year earlier but down 15.01 percentage points from the prior quarter.

Analysis

Immucell (ICCC) EBIT Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immucell's EBIT Margin was 14.47% through Sep 30, 2026, up 6.08 percentage points year-over-year; for FY2025, it was 5.97%, up 12.16 percentage points from FY2024.

  • EBIT Margin shows a five-year change of +14.96 percentage points (FY2020 to FY2025).
  • In earlier years, EBIT Margin was -6.19% in FY2024 (+26.71 pp), -32.90% in FY2023 (-20.52 pp), -12.38% in FY2022 (-13.72 pp) and 1.34% in FY2021 (+10.33 pp).
  • Quarterly EBIT Margin has moved between -65.46% (Q1 2023) and 26.93% (Q2 2026) over five years.
  • Compared with a year earlier, EBIT Margin has increased for three straight quarters, with an average year-over-year change of +12.59 percentage points over the last seven quarters.
  • The best year-over-year quarter for EBIT Margin over five years was Q1 2024 (a gain of 61.32 percentage points); the worst was Q1 2023 (a drop of 74.97 percentage points).
  • Per Business Quant data, ICCC's EBIT Margin in the three quarters before Q3 2026 was 26.93% (Q2 2026), 19.01% (Q1 2026) and -0.76% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 11.91%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.91%
Jun 30, 2026 26.93%
Mar 31, 2026 19.01%
Dec 31, 2025 -0.76%
Sep 30, 2025 0.36%
Jun 30, 2025 8.84%
Mar 31, 2025 13.85%
Dec 31, 2024 8.02%
Sep 30, 2024 -9.56%
Jun 30, 2024 -25.34%
Mar 31, 2024 -4.13%
Sep 30, 2023 -21.94%
Jun 30, 2023 -36.93%
Mar 31, 2023 -65.46%
Dec 31, 2022 -41.77%
Sep 30, 2022 -12.86%
Jun 30, 2022 -16.03%
Mar 31, 2022 9.51%
Dec 31, 2021 2.67%
Sep 30, 2021 5.26%
API Access

Immucell EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY